Cambridge Investment Research Advisors
GWPH

Cambridge Investment Research Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,850
Closed -$1.49M – 3199
2021
Q1 		$1.49M Sell
6,850
-19,838
-74% -$3.73M 0.01% 1183
2020
Q4 		$3.08M Sell
26,688
-2,879
-10% -$323K 0.02% 706
2020
Q3 		$2.88M Buy
29,567
+9,192
+45% +$1.06M 0.02% 639
2020
Q2 		$2.5M Sell
20,375
-1,008
-5% -$114K 0.02% 678
2020
Q1 		$1.87M Buy
21,383
+10,598
+98% +$1.12M 0.02% 698
2019
Q4 		$1.13M Buy
10,785
+1,009
+10% +$113K 0.01% 1079
2019
Q3 		$1.13M Sell
9,776
-530
-5% -$80.4K 0.01% 1005
2019
Q2 		$1.78M Sell
10,306
-838
-8% -$145K 0.02% 768
2019
Q1 		$1.88M Buy
11,144
+744
+7% +$111K 0.02% 741
2018
Q4 		$1.01M Buy
10,400
+4,630
+80% +$607K 0.01% 929
2018
Q3 		$997K Buy
5,770
+91
+2% +$13.1K 0.01% 1030
2018
Q2 		$792K Buy
5,679
+2,273
+67% +$323K 0.01% 1116
2018
Q1 		$384K Buy
3,406
+1,224
+56% +$154K ﹤0.01% 1499
2017
Q4 		$288K Sell
2,182
-127
-6% -$14.9K ﹤0.01% 1685
2017
Q3 		$234K Buy
2,309
+189
+9% +$20.2K ﹤0.01% 1717
2017
Q2 		$213K Buy
+2,120
New +$228K ﹤0.01% 1717
2014
Q4 		– Sell
-2,668
Closed -$216K – 1511
2014
Q3 		$216K Buy
+2,668
New +$236K 0.01% 1262

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Cambridge Investment Research Advisors's GWPH Position: Q2 2021 in Review

Cambridge Investment Research Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 6,850 shares — an estimated $1.49M sold.

Cambridge Investment Research Advisors first reported a position in GWPH in Q3 2014 and held it in 17 quarters. The position peaked at $3.08M in Q4 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Cambridge Investment Research Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 6,850 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.49M.
  • Cambridge Investment Research Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2014 and held it in 17 quarters.
  • Cambridge Investment Research Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.08M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.